Literature DB >> 1148501

Effect of fluphenazine on tissue noradrenaline concentrations and its interaction with pargyline.

R A Azhary, M T Khayyal, S Saleh.   

Abstract

Fluphenazine caused a small decrease in the noradrenaline (NA) concentrations of the rat brain, possibly by impairing granular amine storage. The drug diminished the rise in brain and heart NA concentrations induced by pargyline, suggesting that it might posses inhibitory properties on neuronal uptake mechanisms and/or NA synthesis. Fluphenazine abolished conditioned avoidance responses in rats, an effect which was maintained after the concomitant administration of pargyline, when NA concentrations remained high. This suggests that the fluphenazine-induced sedation is not mediated via its effect on brain NA content, but is possibly due to the effect of the drug on NA turnover rates in the brain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1148501      PMCID: PMC1666309          DOI: 10.1111/j.1476-5381.1975.tb07399.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  EFFECTS OF CHLORPROMAZINE ON THE METABOLISM OF DL-2-C14-DOPA IN THE RAT.

Authors:  K F GEY; A PLETSCHER
Journal:  J Pharmacol Exp Ther       Date:  1964-09       Impact factor: 4.030

2.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

3.  Relation between norepinephrine accumulation or depletion and blood pressure responses in the cat and rat following pargyline administration.

Authors:  H G SCHOEPKE; R G WIEGAND
Journal:  Ann N Y Acad Sci       Date:  1963-07-08       Impact factor: 5.691

4.  Influence of chlorpromazine and chlorprothixene on the cerebral metabolism of 5-hydroxytryptamine, norepinephrine and dopamine.

Authors:  K F GEY; A PLETSCHER
Journal:  J Pharmacol Exp Ther       Date:  1961-07       Impact factor: 4.030

5.  Behavioral effects of some psychopharmacological agents.

Authors:  L COOK; E WEIDLEY
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

6.  Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. II. Structural requirements for D-amino acid oxidase inhibition.

Authors:  S Gabay; S R Harris
Journal:  Biochem Pharmacol       Date:  1966-03       Impact factor: 5.858

7.  Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. 3. Inhibition kinetics with highly purified D-amino acid oxidase.

Authors:  S Gabay; S R Harris
Journal:  Biochem Pharmacol       Date:  1967-05       Impact factor: 5.858

Review 8.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

9.  The comparative effectiveness of eight phenothiazines.

Authors:  T E Hanlon; M H Michaux; K Y Ota; J W Shaffer; A A Kurland
Journal:  Psychopharmacologia       Date:  1965-02-15

Review 10.  Monoamine oxidase inhibitors.

Authors:  A Pletscher
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.